Get started
Author

S. Deepika

Observed names: Deepika S., S S Pranaya Deepika, Seervi Deepika
Institution: Christ University
ORCID: 0009-0003-5023-1050
Observed ORCID: 0009-0003-5023-1050
OpenAlex ID: A5008643752
Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer
2024 · Snita Sinukumar, Dileep Damodaran, et al. · Frontiers in Oncology · 5
Measurement of Nasal Mucociliary Clearance in Indian Adults: Normative Data
2023 · Chethana R, Prasun Mishra, et al. · Indian Journal of Otolaryngology and Head & Neck Surgery · 2
PDF
Fungal metabolites: Nature’s key to antiangiogenic cancer therapies
2025 · Seervi Deepika, Sarojini Suma, et al. · Plant Science Today · 1
PDF
Role of perioperative tranexamic acid in reducing drain volume in breast cancer patients undergoing axillary lymph node dissection: A randomized controlled trial
2022 · S. Deepika, P. Jain, et al. · European Journal of Cancer · 1
PDF
Young Colo-rectal Cancer: Demographic, Clinicopathologic and Survival Data from a tertiary centre in Eastern India
2024 · P. Narayanan, P. Saha, et al. · European Journal of Surgical Oncology
Clinico-pathological Profile of Triple-negative Breast Cancer (TNBC) And Comparative Analysis Of Oncological Outcomes Of TNBC Vs. Non-TNBC: A Tertiary Care Centre Experience From Eastern India
2024 · P. Saha, S. Deepika, et al. · European Journal of Surgical Oncology
Non-Inflammatory skin involvement in Breast Cancer (T4b): Real-world Data from a Tertiary care centre in Eastern India
2022 · S. Deepika, P. Jain, et al. · European Journal of Cancer
Works count: 7
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type